Holen Sie sich die Stockscreener-App
488.19
1.45%
7.3197
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$480.87
Offen:
$482.99
24-Stunden-Volumen:
33,048
Relative Volume:
0.14
Marktkapitalisierung:
$6.48B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$259.78M
KGV:
26.60
EPS:
18.3497
Netto-Cashflow:
$377.12M
1W Leistung:
+7.65%
1M Leistung:
+16.93%
6M Leistung:
+15.11%
1J Leistung:
+3.52%
1-Tages-Spanne:
$479.71
$488.49
1-Wochen-Bereich:
$452.53
$488.20
52-Wochen-Spanne:
$365.20
$488.20
Chemed Corp Stock (CHE) Company Profile
Firmenname
Chemed Corp
Sektor
Branche
Telefon
(513)762-6690
Adresse
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
488.08 | 6.18B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
414.72 | 86.49B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
205.60 | 16.11B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
235.94 | 14.28B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.68 | 12.14B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
105.15 | 10.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-02 | Hochstufung | Jefferies | Hold → Buy |
| 2025-07-25 | Eingeleitet | Jefferies | Hold |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Buy |
| 2018-10-12 | Eingeleitet | BofA/Merrill | Buy |
| 2017-08-28 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Bestätigt | Oppenheimer | Outperform |
| 2015-10-26 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Bestätigt | Oppenheimer | Outperform |
| 2014-09-23 | Bestätigt | Oppenheimer | Outperform |
| 2014-06-10 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2013-09-10 | Bestätigt | Deutsche Bank | Hold |
| 2011-03-04 | Bestätigt | Barclays Capital | Underweight |
| 2011-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2011-02-17 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Chemed Corp Aktie (CHE) Neueste Nachrichten
Chemed Corp (CHE) Shares Surge 3.2% -- What GF Score of 86 Tells Investors - GuruFocus
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29 - GlobeNewswire
Formidable Asset Management LLC Decreases Stake in Chemed Corporation $CHE - MarketBeat
Fort Washington Investment Advisors Inc. OH Has $23.52 Million Stake in Chemed Corporation $CHE - MarketBeat
Should You Hold Chemed Stock in Your Portfolio Now? - Yahoo Finance
Chemed Corporation Actuals & Estimates (NYSE:CHE) - TradingView
CHE Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Chemed Corp – NYSE:CHE - TradingView
Price to sales forward of Chemed Corp – NYSE:CHE - TradingView
Price to earnings forward of Chemed Corp – NYSE:CHE - TradingView
Enterprise value to revenue forward of Chemed Corp – NYSE:CHE - TradingView
Enterprise value to EBITDA forward of Chemed Corp – NYSE:CHE - TradingView
Behavioral Patterns of CHE and Institutional Flows - Stock Traders Daily
VITAS Healthcare Hospice Services from Chemed Corpquiet support for complex end-of-life care in t - AD HOC NEWS
Chemed Corp (CHE) Stock Analysis: Evaluating Its Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Chemed Corp (CHE) Institutional Confidence - TradingKey
Chemed StockLong-term hospice and plumbing model under review - AD HOC NEWS
Is Chemed (NYSE:CHE) Ready For A Valuation Rebound? - Kalkine Media
Quietly essential in a crisis, Roto-Rooter Water Restoration goes beyond clogged drains - AD HOC NEWS
Chemed Corp (CHE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Chemed Corp (CHE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Chemed Corp (CHE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Chemed Corp (CHE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Chemed Corp (CHE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Chemed Corp (CHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Chemed Corp (CHE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Chemed Corp (CHE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Chemed (CHE) Stock Valuation Check After Recent Mixed Performance And Undervaluation Debate - Yahoo Finance
Epoch Investment Partners Inc. Has $137.95 Million Stock Position in Chemed Corporation $CHE - MarketBeat
(CHE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Director Andrea Lindell Sells 1,347 Shares of Chemed Corp (CHE) - GuruFocus
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. By Investing.com - Investing.com South Africa
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. - Investing.com
Director Lindell sells 1,347 Chemed (NYSE: CHE) shares at $447.33 - Stock Titan
Roto-Rooter Services Company Acquires South Texas Franchise for $12 Million - Quiver Quantitative
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas - GlobeNewswire
Chemed Corp (CHE) Stock Analysis: A Robust Healthcare Play With Solid Financial Metrics - DirectorsTalk Interviews
ETFs Investing in Chemed Corporation Stocks - TradingView
VITAS CEO: CMS’ National Moratorium Disappointing - Hospice News
TD Asset Management Inc Has $138.86 Million Stock Holdings in Chemed Corporation $CHE - MarketBeat
Activist Barington targets healthcare firm Chemed - MSN
Chemed Corp (CHE) Moves Higher as Stock Tests Technical Resistance LevelsNHNL Ratio - dars.gov.et
Activist Barington Targets Healthcare Firm Chemed - Bloomberg.com
Chemed edges higher on report activist Barington has taken a stake - Seeking Alpha
CHE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (CHE) Movements Inform Risk Allocation Models - Stock Traders Daily
Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside - DirectorsTalk Interviews
CHE Technical Analysis & Stock Price Forecast - Intellectia AI
Chemed director Walsh sells $218,915 in stock By Investing.com - Investing.com Australia
Chemed Corp (CHE) Shares Fall 3.1% -- What GF Score of 78 Tells Investors - GuruFocus
Chemed director Walsh sells $218,915 in stock - Investing.com
Finanzdaten der Chemed Corp-Aktie (CHE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):